	Bilateral breast treatment in a single arc using RapidArc Dynamic: A planning comparison with conventional volumetric modulated arc therapy. J Appl Clin Med Phys Li T, Cozzi L, Rosa L, Clark R, Agarwal P, Gao Y, Yang Y, Teo BK, Magliari A, Kalra H, Reynoso F, Kupelian P, Beriwal S. PMID: 41272934 [PubMed - indexed for MEDLINE]
	Genome-wide association study of Asian women identifies putative mammographic density-associated loci. Breast Cancer Res Mariapun S, Eriksson M, Tai MC, Mohd Taib NA, Yip CH, Rahmat K, Vachon CM, Lindstrom S, Li J, Hartman M, Hall P, Easton DF, Ho WK, Teo SH. PMID: 41272850 [PubMed - indexed for MEDLINE]
	Effects of varying-dose dexmedetomidine-assisted anesthesia on postoperative delirium in elderly patients undergoing radical mastectomy for breast cancer: a randomized controlled trial. Eur J Med Res Qiang L, Bin Z, Xiaozhi J, Shanshan Z, Qiaoyan W. PMID: 41272708 [PubMed - indexed for MEDLINE]
	Bridging pharmacovigilance and genetic insight: investigating drugs and indications for breast cancer risk in women with autoimmune diseases. J Transl Med Song N, Xi X, Zhang K, Li Z, Kuan Y, Pei C. PMID: 41272700 [PubMed - indexed for MEDLINE]
	Prognostic value of lymphocyte-to-monocyte ratio for breast cancer: a systematic review and meta-analysis. BMC Womens Health Zhu L, Qiao J, Yang C, Ruan X, Wu S. PMID: 41272609 [PubMed - indexed for MEDLINE]
	Clinical outcomes of ultrasound-guided mammotome vacuum-assisted excision for benign breast tumors and its impact on serum tumor markers. BMC Surg He Y, Sun Q, Zhou C, Liu R, Zou LL, Chen H. PMID: 41272573 [PubMed - indexed for MEDLINE]
	Establishment of a new method for detection of TROP2-positive circulating tumor cells in breast cancer. BMC Cancer Wang A, Zeng P, Ma T, Shi H, Li R, Xu H, Feng Y, Liu Q, Wang M, Chen T, Hu Z, Wang R, Zhou Y, Hao X. PMID: 41272532 [PubMed - indexed for MEDLINE]
	Safety and efficacy of immune checkpoint inhibitors in patients with triple-negative breast cancer: a systematic review and meta-analysis. BMC Cancer Yan X, Zhang X, Wang Z, Yang L. PMID: 41272529 [PubMed - as supplied by publisher]
	Effects of a multimodal physical therapy approach on breast cancer-related lymphedema: a retrospective pre-post study. Sci Rep R DV, Venugopalan M, Arumugam A, Migliorini F, Maffulli N, Seenivasagam RK. PMID: 41272224 [PubMed - in process]
	Intermittent pneumatic compression devices for the prevention and treatment of breast cancer-related lymphedema-a systematic review and meta-analysis. Support Care Cancer Su L, Huang H, Tong Y, Dong L, Gu C, Zhuang S, Bai S, Jin Y. PMID: 41272206 [PubMed - indexed for MEDLINE]
	SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer. Sci Rep Guo Y, Zhou X, Xu H, Wang G. PMID: 41271917 [PubMed - indexed for MEDLINE]
	The relationship between CTCs, TFD and postoperative prognosis of cervical cancer patients and the construction of prediction models. Sci Rep Zhang Z, Li B, Li W, Wang Z, Yu Q. PMID: 41271896 [PubMed - indexed for MEDLINE]
	Dynamic conditional survival nomogram for non-early-stage infiltrating ductal carcinoma based on SEER database. Sci Rep Tan E, Chen T, Hao H, Gao W, Guo S, Cui H, Song B. PMID: 41271881 [PubMed - indexed for MEDLINE]
	Proinflammatory markers in women with type 1 diabetes and polycystic ovary syndrome. Sci Rep García-Sáenz MR, López-Juárez N, Valencia-Ortega J, Saucedo R, Lobaton-Ginsberg M, Ramirez-Renteria C, Leon-Wu K, Sosa-Eroza E, Espinosa-Cárdenas E, Ferreira-Hermosillo A. PMID: 41271850 [PubMed - indexed for MEDLINE]
	Determinants of delay in presentation to completion of treatment in cervical cancer. Sci Rep Begum D, Bassetty KC, Barmon D, Baruah U, Nath J, Khanikar D, Roy PS, Bhattacharyya M, Ahmed S, Kumar M, Baruah C. PMID: 41271829 [PubMed - indexed for MEDLINE]
	Development and validation of the risk stratification based on deep learning and radiomics to predict survival of advanced cervical cancer. Sci Rep Guy MM, Mao Z, Yu Y, Liu Y, Bian T, Liu Q, Li N, Hao Y, Cui B. PMID: 41271823 [PubMed - indexed for MEDLINE]
	Phase Ib study of intratumoral talimogene laherparepvec (T-VEC) in combination with chemotherapy or endocrine therapy in patients with advanced HER2-negative breast cancer. NPJ Breast Cancer Huppert LA, Gliwa AS, Tait M, Quintal L, Starzinski S, Cheung A, Moasser M, Majure M, Melisko M, Munster P, Rugo HS, Campbell M, Fong L, Chien AJ. PMID: 41271741 [PubMed]
	Adherence to Choosing Wisely Africa recommendations in breast cancer care: a cross-sectional study across three Sub-Saharan African centres. BMJ Open Rubagumya F, Rugengamanzi E, Nyagabona SK, Ndumbalo J, Kwizera V, Uwimbabazi A, Celyna K, Ayettey H, Vanderpuye V, Hopman WM, Hammad N, Booth CM. PMID: 41271416 [PubMed - indexed for MEDLINE]
	Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial. J Natl Cancer Inst Wortelboer N, Kent S, Blommestein HM, van Ommen-Nijhof A, van der Noort V, van den Pol E, Páez CG, Beeker A, Beelen K, Hamming LC, Heijns JB, Honkoop AH, de Jong PC, van Rossum-Schornagel QC, van de Mheen CVS, Tol J, Driel CST, Vrijaldenhoven S, van Leeuwen-Stok AE, Sonke GS, Jager A, Konings IR. PMID: 41270788 [PubMed - as supplied by publisher]
	Angiotensin converting enzyme inhibitors and angiotensin receptor blockers and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) study. Cancer Epidemiol Majidi A, Na R, Jordan SJ, Ross TL, DeFazio A, Friedlander M, Grant P, Webb PM. PMID: 41270664 [PubMed - as supplied by publisher]

Articles 1 - 20 / 320556

Page 1 of 16028



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy